BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 26579433)

  • 1. Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.
    Li G; L Guo G
    Acta Pharm Sin B; 2015 Mar; 5(2):93-8. PubMed ID: 26579433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid nuclear receptor FXR and digestive system diseases.
    Ding L; Yang L; Wang Z; Huang W
    Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
    Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
    Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism.
    Kwong E; Li Y; Hylemon PB; Zhou H
    Acta Pharm Sin B; 2015 Mar; 5(2):151-7. PubMed ID: 26579441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice.
    Borude P; Edwards G; Walesky C; Li F; Ma X; Kong B; Guo GL; Apte U
    Hepatology; 2012 Dec; 56(6):2344-52. PubMed ID: 22730081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis.
    Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Hirayama T; Tint GS; Doy M; Shefer S
    J Lipid Res; 2005 Feb; 46(2):287-96. PubMed ID: 15576845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acids are nutrient signaling hormones.
    Zhou H; Hylemon PB
    Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of farnesoid X receptor and bile acids in alcoholic liver disease.
    Manley S; Ding W
    Acta Pharm Sin B; 2015 Mar; 5(2):158-67. PubMed ID: 26579442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice.
    Péan N; Doignon I; Garcin I; Besnard A; Julien B; Liu B; Branchereau S; Spraul A; Guettier C; Humbert L; Schoonjans K; Rainteau D; Tordjmann T
    Hepatology; 2013 Oct; 58(4):1451-60. PubMed ID: 23686672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policosanol alleviates hepatic lipid accumulation by regulating bile acids metabolism in C57BL6/mice through AMPK-FXR-TGR5 cross-talk.
    Zhai Z; Niu KM; Liu H; Lin C; Tu Y; Liu Y; Cai L; Ouyang K; Liu J
    J Food Sci; 2021 Dec; 86(12):5466-5478. PubMed ID: 34730235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.
    Honda A; Miyazaki T; Iwamoto J; Hirayama T; Morishita Y; Monma T; Ueda H; Mizuno S; Sugiyama F; Takahashi S; Ikegami T
    J Lipid Res; 2020 Jan; 61(1):54-69. PubMed ID: 31645370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual bile acids have differential effects on bile acid signaling in mice.
    Song P; Rockwell CE; Cui JY; Klaassen CD
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
    Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
    Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.
    Liu H; Pathak P; Boehme S; Chiang JL
    J Lipid Res; 2016 Oct; 57(10):1831-1844. PubMed ID: 27534992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
    Song KH; Li T; Owsley E; Strom S; Chiang JY
    Hepatology; 2009 Jan; 49(1):297-305. PubMed ID: 19085950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid homeostasis in female mice deficient in
    Rizzolo D; Kong B; Taylor RE; Brinker A; Goedken M; Buckley B; Guo GL
    Acta Pharm Sin B; 2021 Dec; 11(12):3847-3856. PubMed ID: 35024311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
    Hu X; Bonde Y; Eggertsen G; Rudling M
    J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.